Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW


Palbociclib capsules, the English name is Palbociclib, and the trade name is Ibrance. This is an oral cyclin-dependent kinase (CDKs) 4 and 6 inhibitor. CDKs 4 and 6 are key regulators of the cell cycle, triggering cell cycle progression. Aibexin’s approved indication in the United States is for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer, in combination with aromatase inhibitors. As initial endocrine therapy in postmenopausal women. As of 2018, it has been approved for marketing in 86 countries and regions around the world, with China being the 87th.


Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.